liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
CDC73/HRPT2 CpG island hypermethylation and mutation of 5 -untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors
University of Sydney.
University of Sydney.
University of Sydney.
University of Sydney.
Show others and affiliations
2010 (English)In: ENDOCRINE-RELATED CANCER, ISSN 1351-0088, Vol. 17, no 1, 273-282 p.Article in journal (Refereed) Published
Abstract [en]

The tumor suppressor HRPT2/CDC73 is mutated in constitutive DNA from patients with the familial disorder hyperparathyroidism-jaw tumor syndrome and in similar to 70% of all parathyroid carcinomas. In a number of HRPT2 mutant tumors however, expression of the encoded protein parafibromin is lost in the absence of a clear second event such as HRPT2 allelic loss or the presence of a second mutation in this tumor suppressor gene. We sought to determine whether hypermethylation of a 713 bp CpG island extending 648 nucleotides upstream of the HRPT2 translational start site and 65 nucleotides into exon 1 might be a mechanism contributing to the loss of expression of parafibromin in parathyroid tumors. Furthermore, we asked whether mutations might be present in the 5-untranslated region (5-UTR) of HRPT2. We investigated a pool of tissue from 3 normal parathyroid glands, as well as 15 individual parathyroid tumor samples including 6 tumors with known HRPT2 mutations, for hypermethylation of the HRPT2 CpG island. Methylation was not identified in any specimens despite complete loss of parafibromin expression in two parathyroid carcinomas with a single detectable HRPT2 mutation and retention of the wild-type HRPT2 allele. Furthermore, no mutations of a likely pathogenic nature were identified in the 5-UTR of HRPT2. These data strongly suggest that alternative mechanisms such as mutation in HRPT2 intronic regions, additional epigenetic regulation such as histone modifications, or other regulatory inactivation mechanisms such as targeting by microRNAs may play a role in the loss of parafibromin expression.

Place, publisher, year, edition, pages
2010. Vol. 17, no 1, 273-282 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-54711DOI: 10.1677/ERC-09-0291ISI: 000275663100025OAI: oai:DiVA.org:liu-54711DiVA: diva2:308403
Available from: 2010-04-06 Created: 2010-04-06 Last updated: 2010-04-19

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Gimm, Oliver

Search in DiVA

By author/editor
Gimm, Oliver
By organisation
Department of Clinical and Experimental MedicineFaculty of Health SciencesDepartment of Surgery in Östergötland
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 57 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf